688235.SH
BeOne Medicines Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 276.67
−4.35%Margins
Gross margin
88.3%
EBITDA margin
8.9%
EBIT margin
10.5%
Net margin
7.8%
FCF margin
34.2%
9.6%
Return on equity
5.4%
Return on assets
10.5%
Return on invested capital
0.70x
Asset turnover
CNY 15.3B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026